Cite

HARVARD Citation

    Mazières, J. et al. (n.d.). 1488PVemurafenib in patients (pts) harboring BRAF V600 mutation: Results of non-small cell lung cancer (NSCLC) cohort from the AcSé trial. Annals of oncology. p. . [Online]. 
  
Back to record